Global Opioid-Induced Constipation Competitive Landscape Professional Research Report 2024

Research Summary

Opioid-induced constipation (OIC) is a common and distressing side effect associated with the use of opioid medications for pain management. Opioids, which include prescription medications like morphine and oxycodone, as well as illicit drugs such as heroin, can slow down the digestive system and lead to infrequent, difficult, and painful bowel movements. OIC can cause significant discomfort, impact a person's quality of life, and, if left untreated, may result in serious complications such as bowel blockages. Healthcare providers often recommend various treatments, including lifestyle changes, dietary modifications, and specific medications, to alleviate OIC and improve the overall well-being of individuals on opioid therapy while ensuring effective pain management.

According to DIResearch's in-depth investigation and research, the global Opioid-Induced Constipation market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Opioid-Induced Constipation include Ironwood Pharmaceuticals, Daiichi Sankyo, Pfizer, Progenics Pharmaceuticals, Shionogi, Allergan, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma, Mundipharma International, Ono Pharmaceutical, Takeda Pharmaceutical Company, Theravance Biopharma, Bausch Health, Cosmo Pharmaceuticals, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Opioid-Induced Constipation. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Opioid-Induced Constipation market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Opioid-Induced Constipation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Opioid-Induced Constipation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Opioid-Induced Constipation Include:

Ironwood Pharmaceuticals

Daiichi Sankyo

Pfizer

Progenics Pharmaceuticals

Shionogi

Allergan

Nektar Therapeutics

Purdue Pharma

S.L.A. Pharma

Mundipharma International

Ono Pharmaceutical

Takeda Pharmaceutical Company

Theravance Biopharma

Bausch Health

Cosmo Pharmaceuticals

Daewoong Pharmaceutical

C.B. Fleet Company

Sucampo Pharmaceuticals

Opioid-Induced Constipation Product Segment Include:

Lubiprostone

Methylnaltrexone Bromide

Naldemedine

Alvimopan

Others

Opioid-Induced Constipation Product Application Include:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Opioid-Induced Constipation Industry PESTEL Analysis

Chapter 3: Global Opioid-Induced Constipation Industry Porter's Five Forces Analysis

Chapter 4: Global Opioid-Induced Constipation Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Opioid-Induced Constipation Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Opioid-Induced Constipation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Opioid-Induced Constipation Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Opioid-Induced Constipation Market Overview

1.1 Product Definition and Statistical Scope

1.2 Opioid-Induced Constipation Product by Type

1.2.1 Global Opioid-Induced Constipation Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Lubiprostone

1.2.3 Methylnaltrexone Bromide

1.2.4 Naldemedine

1.2.5 Alvimopan

1.2.6 Others

1.3 Opioid-Induced Constipation Product by Application

1.3.1 Global Opioid-Induced Constipation Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Opioid-Induced Constipation Market Revenue and Sales Analysis

1.4.1 Global Opioid-Induced Constipation Market Size Analysis (2019-2030)

1.4.2 Global Opioid-Induced Constipation Market Sales Analysis (2019-2030)

1.4.3 Global Opioid-Induced Constipation Market Sales Price Trend Analysis (2019-2030)

1.5 Opioid-Induced Constipation Market Development Status and Trends

1.5.1 Opioid-Induced Constipation Industry Development Status Analysis

1.5.2 Opioid-Induced Constipation Industry Development Trends Analysis

2 Opioid-Induced Constipation Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Opioid-Induced Constipation Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Opioid-Induced Constipation Market Analysis by Regions

4.1 Opioid-Induced Constipation Overall Market: 2023 VS 2024 VS 2030

4.2 Global Opioid-Induced Constipation Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Opioid-Induced Constipation Revenue and Market Share by Region (2019-2024)

4.2.2 Global Opioid-Induced Constipation Revenue Forecast by Region (2025-2030)

4.3 Global Opioid-Induced Constipation Sales and Forecast Analysis (2019-2030)

4.3.1 Global Opioid-Induced Constipation Sales and Market Share by Region (2019-2024)

4.3.2 Global Opioid-Induced Constipation Sales Forecast by Region (2025-2030)

4.4 Global Opioid-Induced Constipation Sales Price Trend Analysis (2019-2030)

5 Global Opioid-Induced Constipation Market Size by Type and Application

5.1 Global Opioid-Induced Constipation Market Size by Type

5.1.1 Global Opioid-Induced Constipation Revenue and Forecast Analysis by Type (2019-2030)

5.1.2 Global Opioid-Induced Constipation Sales and Forecast Analysis by Type (2019-2030)

5.2 Global Opioid-Induced Constipation Market Size by Application

5.2.1 Global Opioid-Induced Constipation Revenue and Forecast Analysis by Application (2019-2030)

5.2.2 Global Opioid-Induced Constipation Sales and Forecast Analysis by Application (2019-2030)

6 North America

6.1 North America Opioid-Induced Constipation Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Opioid-Induced Constipation Market Size by Type

6.3.1 North America Opioid-Induced Constipation Sales by Type (2019-2030)

6.3.2 North America Opioid-Induced Constipation Revenue by Type (2019-2030)

6.4 North America Opioid-Induced Constipation Market Size by Application

6.4.1 North America Opioid-Induced Constipation Sales by Application (2019-2030)

6.4.2 North America Opioid-Induced Constipation Revenue by Application (2019-2030)

6.5 North America Opioid-Induced Constipation Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Opioid-Induced Constipation Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Opioid-Induced Constipation Market Size by Type

7.3.1 Europe Opioid-Induced Constipation Sales by Type (2019-2030)

7.3.2 Europe Opioid-Induced Constipation Revenue by Type (2019-2030)

7.4 Europe Opioid-Induced Constipation Market Size by Application

7.4.1 Europe Opioid-Induced Constipation Sales by Application (2019-2030)

7.4.2 ? Europe Opioid-Induced Constipation Revenue by Application (2019-2030)

7.5 Europe Opioid-Induced Constipation Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Opioid-Induced Constipation Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Opioid-Induced Constipation Market Size by Type

8.3.1 China Opioid-Induced Constipation Sales by Type (2019-2030)

8.3.2 China Opioid-Induced Constipation Revenue by Type (2019-2030)

8.4 China Opioid-Induced Constipation Market Size by Application

8.4.1 China Opioid-Induced Constipation Sales by Application (2019-2030)

8.4.2 China Opioid-Induced Constipation Revenue by Application (2019-2030)

9 APAC (excl. China)

9.1 APAC (excl. China) Opioid-Induced Constipation Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Opioid-Induced Constipation Market Size by Type

9.3.1 APAC (excl. China) Opioid-Induced Constipation Sales by Type (2019-2030)

9.3.2 APAC (excl. China) Opioid-Induced Constipation Revenue by Type (2019-2030)

9.4 APAC (excl. China) Opioid-Induced Constipation Market Size by Application

9.4.1 APAC (excl. China) Opioid-Induced Constipation Sales by Application (2019-2030)

9.4.2 APAC (excl. China) Opioid-Induced Constipation Revenue by Application (2019-2030)

9.5 APAC (excl. China) Opioid-Induced Constipation Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Opioid-Induced Constipation Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Opioid-Induced Constipation Market Size by Type

10.3.1 Latin America Opioid-Induced Constipation Sales by Type (2019-2030)

10.3.2 Latin America Opioid-Induced Constipation Revenue by Type (2019-2030)

10.4 Latin America Opioid-Induced Constipation Market Size by Application

10.4.1 Latin America Opioid-Induced Constipation Sales by Application (2019-2030)

10.4.2 Latin America Opioid-Induced Constipation Revenue by Application (2019-2030)

10.5 Latin America Opioid-Induced Constipation Market Size by Country

10.5.1 Mexico

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Opioid-Induced Constipation Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Opioid-Induced Constipation Market Size by Type

11.3.1 Middle East & Africa Opioid-Induced Constipation Sales by Type (2019-2030)

11.3.2 Middle East & Africa Opioid-Induced Constipation Revenue by Type (2019-2030)

11.4 Middle East & Africa Opioid-Induced Constipation Market Size by Application

11.4.1 Middle East & Africa Opioid-Induced Constipation Sales by Application (2019-2030)

11.4.2 Middle East & Africa Opioid-Induced Constipation Revenue by Application (2019-2030)

11.5 Middle East & Africa Opioid-Induced Constipation Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Competition by Manufacturers

12.1 Global Opioid-Induced Constipation Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

12.1.1 Global Opioid-Induced Constipation Market Sales by Key Manufacturers (2020-2024)

12.1.2 Global Opioid-Induced Constipation Market Revenue by Key Manufacturers (2020-2024)

12.1.3 Global Opioid-Induced Constipation Average Sales Price by Manufacturers (2020-2024)

12.2 Opioid-Induced Constipation Competitive Landscape Analysis and Market Dynamic

12.2.1 Opioid-Induced Constipation Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Ironwood Pharmaceuticals

13.1.1 Ironwood Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Ironwood Pharmaceuticals Opioid-Induced Constipation Product Portfolio

13.1.3 Ironwood Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.2 Daiichi Sankyo

13.2.1 Daiichi Sankyo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Daiichi Sankyo Opioid-Induced Constipation Product Portfolio

13.2.3 Daiichi Sankyo Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.3 Pfizer

13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Pfizer Opioid-Induced Constipation Product Portfolio

13.3.3 Pfizer Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.4 Progenics Pharmaceuticals

13.4.1 Progenics Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Portfolio

13.4.3 Progenics Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.5 Shionogi

13.5.1 Shionogi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Shionogi Opioid-Induced Constipation Product Portfolio

13.5.3 Shionogi Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.6 Allergan

13.6.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Allergan Opioid-Induced Constipation Product Portfolio

13.6.3 Allergan Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.7 Nektar Therapeutics

13.7.1 Nektar Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Nektar Therapeutics Opioid-Induced Constipation Product Portfolio

13.7.3 Nektar Therapeutics Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.8 Purdue Pharma

13.8.1 Purdue Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Purdue Pharma Opioid-Induced Constipation Product Portfolio

13.8.3 Purdue Pharma Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.9 S.L.A. Pharma

13.9.1 S.L.A. Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 S.L.A. Pharma Opioid-Induced Constipation Product Portfolio

13.9.3 S.L.A. Pharma Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.10 Mundipharma International

13.10.1 Mundipharma International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Mundipharma International Opioid-Induced Constipation Product Portfolio

13.10.3 Mundipharma International Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.11 Ono Pharmaceutical

13.11.1 Ono Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Ono Pharmaceutical Opioid-Induced Constipation Product Portfolio

13.11.3 Ono Pharmaceutical Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.12 Takeda Pharmaceutical Company

13.12.1 Takeda Pharmaceutical Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Takeda Pharmaceutical Company Opioid-Induced Constipation Product Portfolio

13.12.3 Takeda Pharmaceutical Company Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.13 Theravance Biopharma

13.13.1 Theravance Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Theravance Biopharma Opioid-Induced Constipation Product Portfolio

13.13.3 Theravance Biopharma Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.14 Bausch Health

13.14.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Bausch Health Opioid-Induced Constipation Product Portfolio

13.14.3 Bausch Health Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.15 Cosmo Pharmaceuticals

13.15.1 Cosmo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Cosmo Pharmaceuticals Opioid-Induced Constipation Product Portfolio

13.15.3 Cosmo Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.16 Daewoong Pharmaceutical

13.16.1 Daewoong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Daewoong Pharmaceutical Opioid-Induced Constipation Product Portfolio

13.16.3 Daewoong Pharmaceutical Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.17 C.B. Fleet Company

13.17.1 C.B. Fleet Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 C.B. Fleet Company Opioid-Induced Constipation Product Portfolio

13.17.3 C.B. Fleet Company Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

13.18 Sucampo Pharmaceuticals

13.18.1 Sucampo Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.18.2 Sucampo Pharmaceuticals Opioid-Induced Constipation Product Portfolio

13.18.3 Sucampo Pharmaceuticals Opioid-Induced Constipation Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Opioid-Induced Constipation Industry Chain Analysis

14.2 Opioid-Induced Constipation Industry Upstream Supply Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Opioid-Induced Constipation Typical Downstream Customers

14.4 Opioid-Induced Constipation Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support